Arcus Biosciences Inc
NYSE:RCUS

Watchlist Manager
Arcus Biosciences Inc Logo
Arcus Biosciences Inc
NYSE:RCUS
Watchlist
Price: 23.12 USD 1.81% Market Closed
Market Cap: 3.2B USD

Wall Street
Price Targets

RCUS Price Targets Summary
Arcus Biosciences Inc

Wall Street analysts forecast RCUS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RCUS is 32.74 USD with a low forecast of 16.16 USD and a high forecast of 49.35 USD.

Lowest
Price Target
16.16 USD
30% Downside
Average
Price Target
32.74 USD
42% Upside
Highest
Price Target
49.35 USD
113% Upside
Arcus Biosciences Inc Competitors:
Price Targets
SPRB
Spruce Biosciences Inc
154% Upside
MDXH
MDxHealth SA
107% Upside
RCKT
Rocket Pharmaceuticals Inc
129% Upside
006280
Green Cross Corp
23% Upside
PRQR
ProQR Therapeutics NV
350% Upside
ELDN
Eledon Pharmaceuticals Inc
420% Upside
603087
Gan & Lee Pharmaceuticals
3% Downside
AMGN
Amgen Inc
0% Upside

Revenue
Forecast

Revenue Estimate
Arcus Biosciences Inc

For the last 7 years the compound annual growth rate for Arcus Biosciences Inc's revenue is 111%. The projected CAGR for the next 4 years is 12%.

111%
Past Growth
12%
Estimated Growth
Estimates Accuracy
6%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Arcus Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Arcus Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-55%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RCUS's stock price target?
Price Target
32.74 USD

According to Wall Street analysts, the average 1-year price target for RCUS is 32.74 USD with a low forecast of 16.16 USD and a high forecast of 49.35 USD.

What is Arcus Biosciences Inc's Revenue forecast?
Projected CAGR
12%

For the last 7 years the compound annual growth rate for Arcus Biosciences Inc's revenue is 111%. The projected CAGR for the next 4 years is 12%.

Back to Top